Australian Prescriber podcast

SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.

David Liew talks to Ketaki Sharma, a staff specialist at the National Centre for Immunisation Research and Surveillance, about the latest developments in COVID-19 vaccines and what the future of vaccination looks like in Australia—who needs boosters and which vaccine should they have? Read the full article by Ketaki and her co-author, Jean Li-Kim-Moy, in Australian Prescriber.

This interview was conducted on 21 October 2023.

The Australian Technical Advisory Group on Immunisation released recommendations on the use of monovalent Omicron XBB.1.5 COVID-19 vaccines on 20 November 2023.

David Liew speaks with infectious diseases physician Ella Meumann about COVID-19 testing. With the evolution of the COVID-19 pandemic, they discuss why testing is still important, and the different types of tests available and when they should be done, as well as how the pandemic has affected our virus-testing strategies more generally. Read the full article by Ella and her co-author, Jennifer Robson, in Australian Prescriber.

This interview was conducted on 28 August 2023.

Laura Beaton talks to Gayle Ross, a dermatologist at The Royal Melbourne Hospital, about treating atopic dermatitis, otherwise known as eczema. If you’re itching for more information on the latest treatment options, this conversation will scratch that itch! Read the full article in Australian Prescriber.

Dhineli Perera talks to Dr David Liew, clinical pharmacologist and rheumatologist, and Elizabeth Su, clinical pharmacist. David and Liz share their experiences working in medicines stewardship and outline the objectives and broad strategies used in stewardship programs. Read the full article in Australian Prescriber.

Justin Coleman chats with GP and addiction specialist, Dr Hester Wilson, about Therapeutic Guidelines' first ever Addiction guidelines.

A spoonful of sugar? Dhineli Perera chats with pharmacist Lucinda Smith about some of the tricks and tips that help make the medicine go down. Read the full article in Australian Prescriber.

Justin Coleman chats with Professor Nick Zwar about the latest changes to the Australian Asthma Handbook. These include updated advice on exercise-induced asthma, dosing information, and use of e-cigarettes for smoking cessation.

Justin Coleman chats to gastroenterologist Chris Rayner about gastrointestinal disorders – from the top to the bottom. What's new in the latest guidelines?

David Liew chats with rheumatologist Lyn March and trainee physician Jimmy Zhu about the latest in osteoporosis – how to assess risk, lifestyle factors, and the drugs used to treat. Read the full article in Australian Prescriber.

Dhineli Perera chats to infectious diseases specialist Anna Ralph about acute rheumatic fever and rheumatic heart disease. Who gets these conditions, how are they diagnosed, and how do we manage them? Read the full article in Australian Prescriber.

Dhineli Perera chats to nephrologist Gopi Rangan about autosomal dominant polycystic kidney disease – simple interventions, drug treatment and pain management.  Read the full article in Australian Prescriber.

Laura Beaton chats to sexual health physician Michael Lowy about the causes, assessment and management options for men with erectile dysfunction. Read the full article in Australian Prescriber.

Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton. Read the full article in Australian Prescriber.

Justin Coleman chats to infectious diseases physician Emily Tucker about one of the more common presentations in primary care – sore throat. 

Many people with well-controlled asthma are prescribed unnecessarily high doses of inhaled corticosteroids, which can increase the risk of adverse effects and costs for patients. Laura Beaton chats with respiratory physician Helen Reddel about how to step down treatment. Read the full article in Australian Prescriber.